Sunshine Biopharma Inc (SBFM)
0.84
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.854
+0.01
(+1.67%)
After-Hours: 20:00
Sunshine Biopharma Cash from Financing (Quarterly): -0.0305M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.0305M |
| September 30, 2023 | -0.0636M |
| June 30, 2023 | 4.058M |
| March 31, 2023 | -0.5383M |
| December 31, 2022 | -2.096M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 29.12M |
| March 31, 2022 | 12.44M |
| December 31, 2021 | -0.0237M |
| September 30, 2021 | 1.276M |
| June 30, 2021 | 0.5506M |
| March 31, 2021 | 1.102M |
| December 31, 2020 | 0.9246M |
| September 30, 2020 | 0.5246M |
| June 30, 2020 | 0.159M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.0902M |
| September 30, 2019 | 0.1327M |
| June 30, 2019 | 0.0048M |
| March 31, 2019 | 0.2147M |
| December 31, 2018 | 0.1728M |
| September 30, 2018 | 0.0917M |
| June 30, 2018 | 0.0146M |
| March 31, 2018 | 0.2486M |
| December 31, 2017 | 0.2142M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.1809M |
| June 30, 2017 | 0.2094M |
| March 31, 2017 | 0.0662M |
| December 31, 2016 | 0.0693M |
| September 30, 2016 | 0.0112M |
| June 30, 2016 | 0.08M |
| March 31, 2016 | 0.1641M |
| December 31, 2015 | 0.8931M |
| September 30, 2015 | 0.0738M |
| June 30, 2015 | 0.3134M |
| March 31, 2015 | 0.1183M |
| December 31, 2014 | 0.2173M |
| September 30, 2014 | 0.1535M |
| June 30, 2014 | 0.15M |
| March 31, 2014 | 0.13M |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.463M |
| December 31, 2012 | 0.05M |
| September 30, 2012 | 0.3525M |
| June 30, 2012 | 0.05M |
| March 31, 2012 | 0.0125M |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.1956M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.096M
Minimum
Dec 2022
29.12M
Maximum
Jun 2022
2.507M
Average
0.1327M
Median
Sep 2019
Cash from Financing (Quarterly) Benchmarks
| Lexaria Bioscience Corp | 3.453M |
| Acasti Pharma Inc | 0.00 |
| Aurinia Pharmaceuticals Inc | -5.577M |
| Edesa Biotech Inc | 0.3057M |
| Xenon Pharmaceuticals Inc | 324.01M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.690M |
| Cash from Investing (Quarterly) | -0.2692M |
| Free Cash Flow | -9.563M |
| Free Cash Flow Per Share (Quarterly) | -12.57 |
| Free Cash Flow to Equity (Quarterly) | -2.993M |
| Free Cash Flow to Firm (Quarterly) | -2.993M |
| Free Cash Flow Yield | -4.70K% |